United We Stand Vs. Divide And Conquer: Pharma In The Age Of Trump
Executive Summary
The pharmaceutical industry fared pretty well in the tumultuous first year of President Trump. But will the industry be able to stay united on key issues in 2018 – or succumb to the divisiveness of the era?